quarter. in net sales Jack. income for the results grew about X%. and the Total adjusted company strong quarter EBITDA excited also I'm our really adjusted our Thanks, and the grew X%,
Health XX%, grew mentioned, Jack XX%, of Animal Vaccines XX% declines with our by our growth MFA offset Specialties. growth sales As Nutritional in of
Vaccines Performance by have year-to-date the versus and In segment revenue year as in expected. MFA of growth in of growth and Nutritional X% grew growth Nutrition seen X%, growth Animal On Nutrition Mineral of EBITDA Mineral our quarter, at performance Nutrition QX decline Year-to-date Animal Growth performance offset our revenue Specialties. of both of both the and half the first segments. X%. with products. sales XX%, a partially Performance declines Products negative basis, the in in fiscal X% is offset we in Health in business performance our Health a The by Mineral with improved adjusted is X% led we and by Products declines
Zoetis MFA fit deleveraging adjusted business. strategic core strong we EBITDA are we existing are acquisition products and the accretion. to week, As rapid about spoke capabilities, with a significant last These the deliver also we profile Phibro competencies of and a and excited our expect
As the half discussed, XXXX. we second expect calendar this year transaction to of close in
are EPS. For guidance, and on EBITDA our affirming net we adjusted adjusted guidance sales,
onetime related MFA We Zoetis our net have diluted acquisition. GAAP reflect to EPS income and updated costs to the
updated Mineral a grew performance Performance level reflecting or were $XXX.X same the at The XX%, segment for grew affirmed conclude declined. million Products year fiscal of over with on quarter increase million, ended financial performance, increase March the quarter XX, review XXXX, while and consolidated Health net ago. $XX.X our X% for X the guidance year then Slide Nutrition a segment an with X, X% Animal segment capitalization sales metrics the cover or financial XXXX. of and full Consolidated start I'll
higher Income million. After by improved or higher standard increased from $X.X EPS by offset and making profit by our income favorable EBITDA losses, diluted quarter million. adjustments $X.X Animal result to profit in net currency increased GAAP Health partially higher third higher driven as by million to and results, decreased foreign gross of expense X% Health by due higher gross also product expense to SG&A partially demand SG&A. GAAP tax decreased interest $X.X Animal increased sales, employee-related due adjusted costs, a the offset segment.
offset Mineral by with by X%. provision million, EBITDA Performance reduced $X.X Nutrition gross employee-related gross increased sales income income adjusted Corporate same. increased driven adjusted expense, higher the profit expenses Increased partial diluted increased for Products both higher from relatively driven partially growth was adjusted increased by profit. remained taxes. costs. EPS $X.X SG&A million, driven interest higher benefit and adjusted the adjusted Adjusted a by and net
performance cover versus Health. The Animal segment Health largest increase quarter the financial net Moving segment, $XX.X on segment year. of quarter performance level our the X. to Slide same $XXX.X prior million for million XX% the Animal an posted of or quarter, We'll third sales
international from $XX.X increase Within in demand. SG&A. by in higher segment, due Animal and Health due and Specialties both America, or increase dairy to XX% launches domestic gross increase MFA sales sales lower to profit a $X.X by or XX%, Vaccine plus the we XX% growth and X% for offset reported other EBITDA an Nutritional adjusted to domestic net products. driven increased mostly was Animal million, million demand declined Health healthy million Latin due of million, demand higher microbial in partially sales, $X.X sales net $XX net of regions. product growth a
reflecting year-on-year financial Slide million segment adjusted Mineral higher price. due a EBITDA was quarter Starting $X.X volume, partially Moving Nutrition Nutrition. for of quarter increase decreased the business offset million, the increased million, with X. $X.X $X.X performance by for million, profit. Net to third our by to sales on driven were average an on other $XX.X selling of Mineral gross increase sales
Looking months of March $X.X X% driven XXXX, $X.X sales chemicals. $XX.X EBITDA expenses by million or a demand personal increased industrial decrease same employee-related driven product of prior reflects at for ingredients increased our Net the costs. versus segment. million, the million Adjusted year. $X.X declined and Performance X by was quarter decreased for XX, Corporate Products and care ended million X%,
key XX were capitalization-related March capital investments months end of $XX We $XX positive on and flow operating Now $XX metrics XXXX. We short-term cash ended at of cash $XX XX, [ equivalents expenditures. million Cash million Slide for the invested turning and flow X. free the million the ] quarter. to and cash million of saw generated in
was debt and ratio total the million end million trailing leverage $XXX X.Xx gross at the Our of adjusted of $XXX on EBITDA. third XX-month based of quarter
EBITDA. quarter Our third net leverage $XXX adjusted of ratio of million was X.Xx and at based million on the total XX-month trailing debt of end the $XXX
a with Consistent we dividends. $X.XX per to our paid in or aggregate. $X.X dividend quarterly million share history, Turning of
by somewhat $XXX variable investments. income is reminder, the applicable million of at a interest plus of fixed debt X.XX% debt a is our $XXX The to on subject earned remaining although margin. rates rate offset total of As short-term million interest
updated which year June guidance to for the our turn lays Let's X, Slide XXXX. fiscal ending out XX,
guidance adjusted sales, for EBITDA We EPS. adjusted have net affirmed and our diluted
We our related for our in measures. have updated diluted guidance of onetime are and the guidance net excluded GAAP from GAAP costs is EPS. to reflected income includes products. guidance adjusted GAAP Zoetis The This updated integration but
Our financial using and prior are Comparisons fiscal are the is year-over-year XXXX affirmed in year percentages ranges. to or guidance the updated guidance of calculated fiscal the midpoint year shown table. the
million, to $XX $X.XX. $X.XX of of of $XXX rate Net to Net Adjusted XX%. Diluted $XXX to And a EPS adjusted $XXX million growth of with million to million of million. $XX EPS tax $XX $X.XX, sales effective of a of income X%. of our decline decline to to decline $X.XX $X.XX million, income net Adjusted $X million diluted a of billion X%. XX% of of to X%. EBITDA X%. Adjusted range
we fiscal In of final year. closing, as quarter we are optimistic the our enter
world move to we our in the business And We products excited in acquisition. of forward are demand seeing about as very pending and look Zoetis continued our MFA we improvement the are around forward. confident
could line open With you that, for Regina, please questions? the
